Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This marks a significant milestone in the diabetes treatment landscape as it introduces a more affordable option for patients managing type 2 diabetes
We're hoping to launch some citizen science trials on peptides shortly (pending FDA go ahead of our IND submission)
Shukla, A.P., Andono, J., Touhamy, S.H., Casper, A., Iliescu, R.G., Mauer, E., Zhu, Y.S., Ludwig, D.S
The India Anti-Obesity Drug Market is estimated to be valued at USD 1.24 Bn in 2026 and is expected to reach USD 4.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 19.7% from 2026 to 2032
US$ 29.14
US$ 25.13
US$ 20.76
US$ 26.92
